The North America Medical Biomimetics Market should witness market growth of 6.2% CAGR during the forecast period (2023-2029).
The utilization of biomimetics in the development of tools and devices for artificially generating organs has increased. This is primarily due to the vulnerability of elderly individuals to organ dysfunction and failure. The growing popularity and acceptance of biomimetics are driving the growth of the organ transplantation industry and are expected to continue to do so in the future. Developing alternative solutions, such as bioengineering, is necessary to complement ongoing efforts to encourage organ donation in all countries.
Numerous businesses are engaged in the creation of products based on biomimetics. Furthermore, the increasing research and development endeavors and the expanding utilization possibilities of medical biomimetics in the diagnostic imaging industry, encompassing ultrasound, ECGs, and CT scans, are anticipated to propel the market expansion.
For instance, some well-known institutes are currently developing a biomimetic flexible, steerable probe. The aim of such studies is to identify the most effective methods for accessing deep brain areas with minimal damage in order to accurately place minimally invasive instrumentation such as electrodes and catheters for deep brain stimulation and perform diagnostic and clinical analysis including localized drug delivery, biopsy, sampling, and micro neurosurgery.
The Pan American Heart Organization (PAHO), 40.8 million disability-adjusted life years (DALYs) are lost to cardiovascular illnesses each year in the North American region. Furthermore, 89% of all CVD DALYs were due to premature deaths, costing 36.4 million years of life (YLLs). The total amount of CVD fatalities and YLDs will probably rise as the population ages and grows. Stroke and ischemic heart disease are the two main underlying disorders that cause death and disability from CVD. Nearly all of the region's non-high-income countries are experiencing an increase in the burden of CVD, and alarmingly, the age-standardized CVD frequency has started to increase in many regions where it had been declining. This will contribute to the market's growth.
The US market dominated the North America Medical Biomimetics Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $17,498.9 Million by 2029. The Canada market is poised to grow at a CAGR of 8.7% during (2023-2029). Additionally, The Mexico market should witness a CAGR of 7.7% during (2023-2029).
Based on Disease Type, the market is segmented into Dental, Orthopedic, Ophthalmology, Cardiovascular and Others. Based on Application, the market is segmented into Wound Healing, Tissue Engineering, Drug Delivery and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., BioHorizons, Inc. (Henry Schein, Inc.), SynTouch Inc., CorNeat Vision Ltd., Osteopore International Pte Ltd, Curasan, Inc., Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.), Swedish Biomimetics 3000 ApS, Keystone Dental Group and Blatchford Limited.
The utilization of biomimetics in the development of tools and devices for artificially generating organs has increased. This is primarily due to the vulnerability of elderly individuals to organ dysfunction and failure. The growing popularity and acceptance of biomimetics are driving the growth of the organ transplantation industry and are expected to continue to do so in the future. Developing alternative solutions, such as bioengineering, is necessary to complement ongoing efforts to encourage organ donation in all countries.
Numerous businesses are engaged in the creation of products based on biomimetics. Furthermore, the increasing research and development endeavors and the expanding utilization possibilities of medical biomimetics in the diagnostic imaging industry, encompassing ultrasound, ECGs, and CT scans, are anticipated to propel the market expansion.
For instance, some well-known institutes are currently developing a biomimetic flexible, steerable probe. The aim of such studies is to identify the most effective methods for accessing deep brain areas with minimal damage in order to accurately place minimally invasive instrumentation such as electrodes and catheters for deep brain stimulation and perform diagnostic and clinical analysis including localized drug delivery, biopsy, sampling, and micro neurosurgery.
The Pan American Heart Organization (PAHO), 40.8 million disability-adjusted life years (DALYs) are lost to cardiovascular illnesses each year in the North American region. Furthermore, 89% of all CVD DALYs were due to premature deaths, costing 36.4 million years of life (YLLs). The total amount of CVD fatalities and YLDs will probably rise as the population ages and grows. Stroke and ischemic heart disease are the two main underlying disorders that cause death and disability from CVD. Nearly all of the region's non-high-income countries are experiencing an increase in the burden of CVD, and alarmingly, the age-standardized CVD frequency has started to increase in many regions where it had been declining. This will contribute to the market's growth.
The US market dominated the North America Medical Biomimetics Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $17,498.9 Million by 2029. The Canada market is poised to grow at a CAGR of 8.7% during (2023-2029). Additionally, The Mexico market should witness a CAGR of 7.7% during (2023-2029).
Based on Disease Type, the market is segmented into Dental, Orthopedic, Ophthalmology, Cardiovascular and Others. Based on Application, the market is segmented into Wound Healing, Tissue Engineering, Drug Delivery and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., BioHorizons, Inc. (Henry Schein, Inc.), SynTouch Inc., CorNeat Vision Ltd., Osteopore International Pte Ltd, Curasan, Inc., Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.), Swedish Biomimetics 3000 ApS, Keystone Dental Group and Blatchford Limited.
Scope of the Study
By Disease Type
- Dental
- Orthopedic
- Ophthalmology
- Cardiovascular
- Others
By Application
- Wound Healing
- Tissue Engineering
- Drug Delivery
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Zimmer Biomet Holdings, Inc.
- BioHorizons, Inc. (Henry Schein, Inc.)
- SynTouch Inc.
- CorNeat Vision Ltd.
- Osteopore International Pte Ltd
- Curasan, Inc.
- Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.)
- Swedish Biomimetics 3000 ApS
- Keystone Dental Group
- Blatchford Limited
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Medical Biomimetics Market by Disease Type
Chapter 5. North America Medical Biomimetics Market by Application
Chapter 6. North America Medical Biomimetics Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Zimmer Biomet Holdings, Inc.
- BioHorizons, Inc. (Henry Schein, Inc.)
- SynTouch Inc.
- CorNeat Vision Ltd.
- Osteopore International Pte Ltd
- Curasan, Inc.
- Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.)
- Swedish Biomimetics 3000 ApS
- Keystone Dental Group
- Blatchford Limited
Methodology
LOADING...
